FIELD: medicine.
SUBSTANCE: invention discloses a method for treating or preventing chemotherapy-induced pain in a subject requiring treatment, comprising administering to the subject a therapeutically effective amount of Compound I or a pharmaceutically acceptable salt thereof.
EFFECT: treatment of pain caused by chemotherapy.
14 cl, 7 dwg, 17 tbl, 7 ex
(I)
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF, OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY OR PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY | 2019 |
|
RU2783733C1 |
| SIGMA-RECEPTOR LIGANDS FOR PREVENTING OR TREATING PAIN CAUSED BY CHEMOTHERAPY | 2010 |
|
RU2543382C2 |
| PREGNANDIONS OR PREGNANDIOLS APPLICATION AS NEUROPATHIC ANALGESIC AGENTS | 2002 |
|
RU2346690C2 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
| SIGMA LIGANDS FOR POTENTIATING ANALGESIC EFFECT OF OPIOIDS AND OPIATES IN POSTOPERATIVE PAIN AND ATTENUATING DEPENDENCY THEREOF | 2011 |
|
RU2563460C2 |
| USE OF BUTYL PHTHALIDE AND ITS DERIVATIVES | 2021 |
|
RU2812533C1 |
| METHOD OF TREATING NEUROPATHIC PAIN AND ASSOCIATED WITH IT SYNDROMES | 2005 |
|
RU2433825C2 |
| USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN | 2012 |
|
RU2608943C2 |
| USING COMPOUNDS BINDING TO SIGMA RECEPTOR LIGANDS FOR TREATING NEUROPATHIC PAIN PROGRESSION CAUSED BY CHEMOTHERAPY | 2009 |
|
RU2537226C2 |
| NEW COMPOSITION FOR TREATING SIDE EFFECTS OF ANTI-CANCER THERAPY | 2008 |
|
RU2485956C2 |
